Planning feasibility of extremely hypofractionated prostate radiotherapy on a 1.5 T magnetic resonance imaging guided linear accelerator

BACKGROUND AND PURPOSE: Recently, intermediate and high-risk prostate cancer patients have been treated in a multicenter phase II trial with extremely hypofractionated prostate radiotherapy (hypo-FLAME trial). The purpose of the current study was to investigate whether a 1.5 T magnetic resonance ima...

Descripción completa

Detalles Bibliográficos
Autores principales: den Hartogh, Mariska D., de Boer, Hans C.J., de Groot-van Breugel, Eline N., van der Voort van Zyp, Jochem R.N., Hes, Jochem, van der Heide, Uulke A., Pos, Floris, Haustermans, Karin, Depuydt, Tom, Jan Smeenk, Robert, Kunze-Busch, Martina, Raaymakers, Bas W., Kerkmeijer, Linda G.W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2019
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7807729/
https://www.ncbi.nlm.nih.gov/pubmed/33458271
http://dx.doi.org/10.1016/j.phro.2019.07.002

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7807729/
https://www.ncbi.nlm.nih.gov/pubmed/33458271
http://dx.doi.org/10.1016/j.phro.2019.07.002

Ejemplares similares